Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A foundation model for generalized brain MRI analysis.
Tak D, Garomsa BA, Chaunzwa TL, Zapaishchykova A, Climent Pardo JC, Ye Z, Zielke J, Ravipati Y, Vajapeyam S, Mahootiha M, Smith C, Familiar AM, Liu KX, Prabhu S, Bandopadhayay P, Nabavizadeh A, Mueller S, Aerts HJ, Huang RY, Poussaint TY, Kann BH. Tak D, et al. Among authors: nabavizadeh a. medRxiv [Preprint]. 2024 Dec 3:2024.12.02.24317992. doi: 10.1101/2024.12.02.24317992. medRxiv. 2024. PMID: 39677480 Free PMC article. Preprint.
Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype Prediction.
Lost J, Verma T, Jekel L, von Reppert M, Tillmanns N, Merkaj S, Petersen GC, Bahar R, Gordem A, Haider MA, Subramanian H, Brim W, Ikuta I, Omuro A, Conte GM, Marquez-Nostra BV, Avesta A, Bousabarah K, Nabavizadeh A, Kazerooni AF, Aneja S, Bakas S, Lin M, Sabel M, Aboian M. Lost J, et al. Among authors: nabavizadeh a. AJNR Am J Neuroradiol. 2023 Oct;44(10):1126-1134. doi: 10.3174/ajnr.A8000. AJNR Am J Neuroradiol. 2023. PMID: 37770204 Free PMC article.
University of Washington Quality of Life subdomain outcomes after treatment of sinonasal malignancy: A prospective, multicenter study.
Maoz SL, Golzar A, Choby G, Hwang PH, Wang EW, Kuan EC, Adappa ND, Geltzeiler M, Getz AE, Humphreys IM, Le CH, Pinheiro-Neto CD, Fischer JL, Chan EP, Abuzeid WM, Chang EH, Jafari A, Kingdom TT, Kohanski MA, Lee JK, Lazor JW, Nabavizadeh A, Nayak JV, Palmer JN, Patel ZM, Resnick AC, Smith TL, Snyderman CH, St John MA, Storm PB, Suh JD, Wang MB, Sim MS, Beswick DM. Maoz SL, et al. Among authors: nabavizadeh a. Int Forum Allergy Rhinol. 2024 Oct;14(10):1568-1581. doi: 10.1002/alr.23386. Epub 2024 Jun 17. Int Forum Allergy Rhinol. 2024. PMID: 38884276
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results.
Bagley SJ, Logun M, Fraietta JA, Wang X, Desai AS, Bagley LJ, Nabavizadeh A, Jarocha D, Martins R, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz R, Jadlowsky JK, Christensen S, Oner BS, Plesa G, Brennan A, Gonzalez V, Chen F, Sun Y, Gladney W, Barrett D, Nasrallah MP, Hwang WT, Ming GL, Song H, Siegel DL, June CH, Hexner EO, Binder ZA, O'Rourke DM. Bagley SJ, et al. Among authors: nabavizadeh a. Nat Med. 2024 May;30(5):1320-1329. doi: 10.1038/s41591-024-02893-z. Epub 2024 Mar 13. Nat Med. 2024. PMID: 38480922 Clinical Trial.
Active Learning in Brain Tumor Segmentation with Uncertainty Sampling and Annotation Redundancy Restriction.
Kim DD, Chandra RS, Yang L, Wu J, Feng X, Atalay M, Bettegowda C, Jones C, Sair H, Liao WH, Zhu C, Zou B, Kazerooni AF, Nabavizadeh A, Jiao Z, Peng J, Bai HX. Kim DD, et al. Among authors: nabavizadeh a. J Imaging Inform Med. 2024 Oct;37(5):2099-2107. doi: 10.1007/s10278-024-01037-6. Epub 2024 Mar 21. J Imaging Inform Med. 2024. PMID: 38514595 Free PMC article.
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma.
Nazem A, Guiry SC, Pourfathi M, Ware JB, Anderson H, Iyer SK, Moon BF, Fan Y, Witschey WR, Rizi R, Bagley SJ, Desai A, O'Rourke DM, Brem S, Nasrallah M, Nabavizadeh A. Nazem A, et al. Among authors: nabavizadeh a. J Neurooncol. 2022 Feb;156(3):645-653. doi: 10.1007/s11060-022-03947-3. Epub 2022 Jan 19. J Neurooncol. 2022. PMID: 35043276
Distinguishing Progression from Pseudoprogression in Glioblastoma Using 18F-Fluciclovine PET.
Nabavizadeh A, Bagley SJ, Doot RK, Ware JB, Young AJ, Ghodasara S, Zhao C, Anderson H, Schubert E, Carpenter EL, Till J, Henderson F Jr, Pantel AR, Chen HI, Lee JYK, Amankulor NM, O'Rourke DM, Desai A, Nasrallah MP, Brem S. Nabavizadeh A, et al. J Nucl Med. 2023 Jun;64(6):852-858. doi: 10.2967/jnumed.122.264812. Epub 2022 Dec 22. J Nucl Med. 2023. PMID: 36549916 Free article.
Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging.
Akbari H, Kazerooni AF, Ware JB, Mamourian E, Anderson H, Guiry S, Sako C, Raymond C, Yao J, Brem S, O'Rourke DM, Desai AS, Bagley SJ, Ellingson BM, Davatzikos C, Nabavizadeh A. Akbari H, et al. Among authors: nabavizadeh a. Sci Rep. 2021 Jul 22;11(1):15011. doi: 10.1038/s41598-021-94560-3. Sci Rep. 2021. PMID: 34294864 Free PMC article.
71 results